Anticancer Drugs Oncology Pharmacology Physiotherapy Topotecan

Topotecan (Mechanism of Action)

In this article we will discuss Topotecan (Mechanism of Action)

In this article, we will discuss Topotecan (Mechanism of Action). So, let’s get started.

Mechanism of Action

Topoisomerase I relieves torsional strain in DNA by inducing reversible single strand breaks. Topotecan binds to the topoisomerase I-DNA complex and prevents religation of these single strand breaks. The cytotoxicity of topotecan is thought to be due to double strand DNA damage produced during DNA synthesis, when replication enzymes interact with the ternary complex formed by topotecan, topoisomerase I, and DNA. Mammalian cells cannot efficiently repair these double strand breaks.


The dose-limiting toxicity of topotecan is leukopenia. White blood cell count decreases with increasing topotecan dose or topotecan AUC. When topotecan is administered at a dose of 1.5 mg/m²/day for 5 days, an 80% to 90% decrease in white blood cell count at nadir is typically observed after the first cycle of therapy

2 replies on “Topotecan (Mechanism of Action)”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.